Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database

Breakpoint cluster region‐Abelson murine leukemia (BCR‐ABL) inhibitors markedly improve the prognosis of chronic myeloid leukemia. However, high treatment adherence is necessary for successful treatment with BCR‐ABL inhibitors. Therefore, an adequate understanding of the adverse event profiles of BC...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancer Med
Main Authors: Okada, Naoto, Niimura, Takahiro, Zamami, Yoshito, Hamano, Hirofumi, Ishida, Shunsuke, Goda, Mitsuhiro, Takechi, Kenshi, Chuma, Masayuki, Imanishi, Masaki, Ishizawa, Keisuke
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2018
נושאים:
Clinical Cancer Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6346261/
https://ncbi.nlm.nih.gov/pubmed/30561126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1920
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים